|Birth||(1943-01-12)January 12, 1943(age 77) New York City,U.S.|
|Birth Place||(age 77) New York City,U.S.|
|Alma Mater||New York University Massachusetts Institute of Technology|
|Institution||Hebrew University of Jerusalem)
Events Occured in Scienctist Life
Howard Chaim Cedar (Hebrew: חיים סידר; born January 12, 1943) is an Israeli American biochemist who works on DNA methylation, a mechanism that turns genes on and off.
He received a bachelor's degree from Massachusetts Institute of Technology (MIT) and, in 1970, received an MD and PhD from New York University.
In 1973 he joined the medical school of the Hebrew University in Jerusalem, and now serves as professor emeritus in the Department for Developmental Biology & Cancer Research, The Institute For Medical Research, Israel-Canada (IMRIC).
In 1999, Cedar was awarded the Israel Prize, for biology.
In 2003, be became a member of the Israel Academy of Sciences and Humanities.
In 2008, he was awarded the Wolf Prize in Medicine, jointly with Aharon Razin, "for their fundamental contributions to our understanding of the role of DNA methylation in the control of gene expression."
In 2009, he was awarded the EMET Prize for his work in cancer research.
In 2011 he received the Canada Gairdner International Award, together with Aharon Razin for their "pioneering discoveries on DNA methylation and its role in gene expression."
In 2016 he received the Louisa Gross Horwitz Prize together with Aharon Razin and Gary Felsenfeld.